Skip to main content
. 2016 Aug 28;22(32):7322–7331. doi: 10.3748/wjg.v22.i32.7322

Table 1.

Expression of heterogeneous nuclear ribonucleoprotein H1protein and its clinical significance in 125 esophageal squamous cell carcinomaspecimens n (%)

Characteristics All cases (n) HNRNPH1
P value1
Negative Weak Strong
Tissues
Normal 125 53 (42.4) 44 (35.2) 28 (22.4) 0.0005
Cancer 125 49 (39.2) 22 (17.6) 54 (43.2)
Age (yr) 0.5422
≥ 60 71 26 (36.6) 16 (22.5) 29 (40.8)
< 60 54 23 (42.6) 6 (11.1) 25 (46.3)
Gender 0.9615
Male 90 34 (37.8) 17 (18.9) 39 (43.3)
Female 35 15 (42.9) 5 (14.2) 15 (42.9)
Tumor differentiation 0.0652
Well 29 15 (51.7) 5 (17.2) 9 (31.1)
Moderately 72 26 (36.1) 16 (22.2) 30 (41.7)
Poorly 24 8 (33.3) 1 (4.2) 15 (62.5)
Tumor differentiation 0.0337
Well + moderately 101 41 (40.6) 21 (20.8) 39 (38.6)
Poorly 24 8 (33.3) 1 (4.2) 15 (62.5)
Lymph Node Metastasis2 0.1839
Present 42 14 (33.3) 9 (21.4) 19 (45.2)
Not present 36 18 (50.0) 7 (19.4) 11 (30.6)
1

The strong expression of HNRNPH1 was compared with negative and weak expression;

2

Only 78 cases had information on lymph node metastasis. HNRNPH1: Heterogeneous nuclear ribonucleoprotein H1; ESCC: Esophageal squamous cell carcinoma.